Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

NKTX

Nkarta (NKTX)

Nkarta Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NKTX
DateHeureSourceTitreSymboleSociété
26/10/202403h44Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:NKTXNkarta Inc
03/09/202422h01GlobeNewswire Inc.Nkarta to Participate in Upcoming Investor ConferenceNASDAQ:NKTXNkarta Inc
23/08/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
14/08/202403h03GlobeNewswire Inc.Correction: Nkarta Reports Second Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
13/08/202422h08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NKTXNkarta Inc
13/08/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NKTXNkarta Inc
13/08/202422h01GlobeNewswire Inc.Nkarta Reports Second Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
31/07/202422h47Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
24/07/202412h00GlobeNewswire Inc.Nkarta Announces Initiation of Investigator-Sponsored Clinical Trial Evaluating NKX019 for Systemic Lupus ErythematosusNASDAQ:NKTXNkarta Inc
16/07/202412h01GlobeNewswire Inc.Nkarta Announces Leadership Updates, Appoints Nadir Mahmood as PresidentNASDAQ:NKTXNkarta Inc
27/06/202412h00GlobeNewswire Inc.Nkarta Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Announces Pipeline Expansion to Additional Autoimmune IndicationsNASDAQ:NKTXNkarta Inc
13/06/202422h01GlobeNewswire Inc.Nkarta Adds Experienced Leader in Autoimmune R&D, George Vratsanos, M.D., FACR, to Board of DirectorsNASDAQ:NKTXNkarta Inc
09/05/202422h01GlobeNewswire Inc.Nkarta Reports First Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
03/04/202422h02GlobeNewswire Inc.Nkarta to Participate in Upcoming Investor ConferencesNASDAQ:NKTXNkarta Inc
25/03/202411h30GlobeNewswire Inc.Nkarta Announces Pricing of $240 Million Underwritten OfferingNASDAQ:NKTXNkarta Inc
21/03/202421h01GlobeNewswire Inc.Nkarta Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
01/03/202422h32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NKTXNkarta Inc
09/02/202412h38Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:NKTXNkarta Inc
03/01/202422h15Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NKTXNkarta Inc
10/12/202302h31GlobeNewswire Inc.Nkarta Presents NKX101 Clinical Data at the 2023 American Society of Hematology Annual Meeting & ExpositionNASDAQ:NKTXNkarta Inc
13/11/202314h25Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:NKTXNkarta Inc
09/11/202322h02GlobeNewswire Inc.Nkarta Reports Third Quarter 2023 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
07/11/202314h02GlobeNewswire Inc.Nkarta to Participate at Upcoming Investor ConferencesNASDAQ:NKTXNkarta Inc
27/10/202322h05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:NKTXNkarta Inc
17/10/202318h00Dow Jones NewsNkarta's Stock Climbs 28% After FDA Approves Drug ApplicationNASDAQ:NKTXNkarta Inc
17/10/202317h47PR Newswire (US)Lupus Therapeutics Announces Partnership to Support the Evaluation of Natural Killer (NK) Cell Therapy in Lupus NephritisNASDAQ:NKTXNkarta Inc
17/10/202313h01GlobeNewswire Inc.Nkarta Receives FDA Clearance of IND Application for NKX019 in Lupus NephritisNASDAQ:NKTXNkarta Inc
16/10/202322h01GlobeNewswire Inc.Nkarta to Host Conference Call on Tuesday, October 17 at 8am ET to Discuss Expansion of Clinical Pipeline and Organizational Cost MeasuresNASDAQ:NKTXNkarta Inc
10/08/202313h01GlobeNewswire Inc.Nkarta Reports Second Quarter 2023 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
03/08/202314h02GlobeNewswire Inc.Nkarta to Participate at Upcoming Investor ConferenceNASDAQ:NKTXNkarta Inc
 Showing the most relevant articles for your search:NASDAQ:NKTX

Dernières Valeurs Consultées